Germany battles colorectal cancer with expanded early detection efforts
Germany battles colorectal cancer with expanded early detection efforts
7,550 Colon Cancer Patients in MV - Drese Campaigns for Prevention - Germany battles colorectal cancer with expanded early detection efforts
Colorectal cancer remains a major health threat in Germany, causing around 23,000 deaths each year—nearly ten times the number of traffic fatalities. In response, health officials are pushing for greater awareness and participation in early detection programs. Mecklenburg-Western Pomerania's health minister, Stefanie Drese, has now urged both the public and employers to take action.
Since April 2022, statutory health insurance in Germany has covered colonoscopy screenings for men and women aged 50 and older. A second screening is offered after ten years if the initial results are negative. Additionally, faecal occult blood tests (iFOBT) are fully reimbursed for the same age group as another early detection method.
In Mecklenburg-Western Pomerania alone, roughly 7,550 people currently live with colorectal cancer, with about 1,200 new cases diagnosed annually. Nationwide, the disease ranks as the second-leading cause of cancer deaths. With an estimated 28 to 29 million Germans aged 50 and above, screening remains a critical tool for reducing mortality. Drese is calling for stronger efforts in education, prevention, and early detection. She has also asked businesses to include colorectal cancer awareness in their workplace health programs. From April 2025, eligible individuals will have the option of an iFOBT every two years or a colonoscopy every ten years.
The push for wider screening participation comes as Germany faces persistently high colorectal cancer death rates. Health officials stress that early detection and lifestyle changes can significantly lower risks. Employers and the public are being encouraged to engage more actively in prevention efforts.